{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:31:57Z","timestamp":1777329117933,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.nrleng.2021.10.005","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T18:09:21Z","timestamp":1662142161000},"page":"557-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gadolinium-enhanced brain lesions in multiple sclerosis relapse"],"prefix":"10.1016","volume":"37","author":[{"given":"L.","family":"Mart\u00edn-Aguilar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Presas-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c0.","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Capellades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Massuet-Vilamaj\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Rami\u00f3-Torrent\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tintor\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Brieva-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Moral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cano-Orgaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Batlle-Nadal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.V.","family":"Herv\u00e1s-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ramo-Tello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2021.10.005_bib0140","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0145","first-page":"178","article-title":"Cerebral lesions of multiple sclerosis: is gadolinium always irreplaceable in assessing lesion activity?","volume":"20","author":"Treab\u01ce","year":"2014","journal-title":"Diagnostic Interv Radiol"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.33588\/rn.6406.2016310","article-title":"Resonancia magn\u00e9tica con gadolinio en la fase aguda de las reca\u00eddas en esclerosis m\u00faltiple","volume":"64","author":"Ortiz Salas","year":"2017","journal-title":"Rev Neurol"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0155","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1177\/1352458507088104","article-title":"Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses","volume":"14","author":"Petkau","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0160","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.11932.1","article-title":"Resolving the clinico-radiological paradox in multiple sclerosis","volume":"6","author":"Chard","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00019052-200206000-00003","article-title":"The clinico-radiological paradox in multiple sclerosis revisited","volume":"15","author":"Barkhof","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0170","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ana.21606","article-title":"Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach","volume":"65","author":"Sormani","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ana.24018","article-title":"Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis","volume":"75","author":"Sormani","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jns.2005.08.006","article-title":"Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis","volume":"239","author":"Tortorella","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0185","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/1352458513508835","article-title":"A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS","volume":"20","author":"Ramo-Tello","year":"2014","journal-title":"Mult Scler J"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0190","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/ene.13851","article-title":"Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial","volume":"26","author":"Herv\u00e1s-Garc\u00eda","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0195","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1191\/1352458504ms1068oa","article-title":"Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis","volume":"10","author":"Nos","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0200","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ana.24497","article-title":"Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque","volume":"78","author":"Frischer","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0205","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012603","article-title":"Association of age with contrast-enhancing lesions across the multiple sclerosis disease spectrum","volume":"97","author":"Koch","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0210","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1212\/WNL.45.6.1122","article-title":"Blood-brain barrier disruption on contrast-enhanced mri in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age","volume":"45","author":"Stone","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0215","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1212\/WNL.56.3.422","article-title":"Enhancement frequency decreases with increasing age in relapsing-remitting multiple sclerosis","volume":"56","author":"Filippi","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0220","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-2008-1040883","article-title":"Multiple sclerosis: use of MRI in evaluating new therapies","volume":"18","author":"Miller","year":"1998","journal-title":"Semin Neurol"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0225","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0230","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1148\/radiol.13131669","article-title":"High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadoliniumbased contrast material","volume":"270","author":"Kanda","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0235","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/RLI.0000000000000154","article-title":"Gadodiamide and dentate nucleus T1 hyperintensity in patients with meningioma evaluated by multiple follow-up contrast-enhanced magnetic resonance examinations with no systemic interval therapy","volume":"50","author":"Quattrocchi","year":"2015","journal-title":"Invest Radiol"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0240","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiol.2015150337","article-title":"Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent","volume":"275","author":"Radbruch","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0245","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1148\/radiol.15150025","article-title":"Intracranial gadolinium deposition after contrast-enhanced MR imaging","volume":"275","author":"McDonald","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0250","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1148\/radiol.2015150872","article-title":"High signal intensity in globus pallidus and dentate nucleus on unenhanced T1-weighted MR images: evaluation of two linear gadolinium-based contrast agents","volume":"276","author":"Ramalho","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0255","unstructured":"EAM. Gadolinium-containing contrast agents | European Medicines Agency. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/gadolinium-containing-contrast-agents [accessed 11.5.20]."},{"key":"10.1016\/j.nrleng.2021.10.005_bib0260","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20160721","article-title":"Multiple sclerosis update: Use of MRI for early diagnosis, disease monitoring and assessment of treatment related complications","volume":"90","author":"Igra","year":"2017","journal-title":"Br J Radiol"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0265","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1474-4422(21)00095-8","article-title":"2021 MAGNIMS\u2013CMSC\u2013NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis","volume":"20","author":"Wattjes","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrleng.2021.10.005_bib0270","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1212\/01.WNL.0000046587.83503.1E","article-title":"MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals","volume":"60","author":"Cotton","year":"2003","journal-title":"Neurology"}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580822000700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580822000700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:33:49Z","timestamp":1761881629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173580822000700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2173580822000700"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2021.10.005","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gadolinium-enhanced brain lesions in multiple sclerosis relapse","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2021.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}